Cilo Cybin Holdings (JSE: CCC)

1.45 now. Down but holding.

1.45 now, that's down almost 3% today.

1.45 down today, hold tight.

1.49, that's a proper run today.

1.49 now. Sharp move today.

R1.49 now, eish. What's driving this?

r0.78 now. ouch.

Yoh, 0.78 now. That's rough.

Good Morning Everyone. R0.78 now, down 36 cents. That's a proper kick in the teeth.

2.00 now! Springboks vibes today!

2.00 now. Eish, what a move!

CCC sitting at a rand seems cheap on the surface but has anyone run the numbers on their cash burn rate and path to profitability. The psychedelics space is still regulatory roulette so I'm curious if anyone's got conviction here or just speculating on sector hype.

CCC at 78c feels undervalued if they can scale clinical ops without bleeding cash, but psychedelics regulation in SA is still murky. Anyone tracking their burn rate and cash position, or is the sector too speculative for dividend hunters like us?

CCC at 78 cents is pricing in a lot of skepticism on the psychedelics space, but has anyone done the math on what revenue needs to look like for this to work at current cap. The sector's got regulatory tailwinds in some jurisdictions. am I missing something on the fundamentals he

Medical cannabis is still fighting for legitimacy here, and CCC's stuck at R0.78 waiting for someone to care. Revenue's there but margins look thin compared to what the big licensed players are doing offshore. If they can actually scale the exports it changes the story, but that's a lot of ifs.

Medical cannabis is still early days globally but the margins on refined oils and isolates are where the real money is, not just flower. CCC's got the extraction tech already in place which puts them ahead of most domestic players. At R0.78 you're pricing in a lot of pessimism, positioned perfectly for when the sector gets its legs back. The future excites me on this one.

CCC sitting at R0.78 and they still havent landed anything material. Medical cannabis space needs real revenue, not just extraction capability. Waiting to see if they can actually shift volume to hospitals or pharmacies, otherwise this stays rangebound.

listen, if you cant see the play here youre looking at the wrong chart. medical cannabis is literally exploding globally and we're still sub-a-rand on the JSE, pre-revenue means nothing when the infrastructure is there. people complain about the price but they're the same ones who'll be crying when this finally gets momentum, ngl.

Not sure about this one. Sitting at R1.00 but where's the actual revenue coming from, the ops look thin. Do you think they can scale the cultivation side fast enough before cash runs dry.

Good day to top up at these levels